Jump to content

SLA - SILK LASER AUSTRALIA LIMITED


ShareCafe

Recommended Posts

  • Replies 43.2k
  • Created
  • Last Reply

Top Posters In This Topic

  • chiller

    2097

  • diana

    1910

  • Livas1

    4166

  • jezzabot

    2629

Top Posters In This Topic

Posted Images

Hi everyone

 

There is a Russian Gastroenterology conference being run on April 28-29 and Ropren is one of the products being presented!

 

But the fascinating thing is, the presentation is being done by Professor Oleg Munishkin and the title of the presentation is "Experience of Polyprenols: Ropren in patients with alcoholic cirrhosis"

 

I think this is terrific news! This is the trial that we are all waiting on, and here is Oleg being confirmed to present the results of the trial to a National conference in a few weeks time!

This seems to indicate that the results of the trial are positive and that Oleg is more than happy to get out and about promoting the product and the results.

This seems to be a significant conference, and with the likes of Boehringer Ingleheim and Abbott sponsoring the conference I can only see positive things coming out the promotion that Solagran and Ropren will receive.

 

Anyway, here are the details

 

http://www.endoscopia.ru/PDF/%D0%9F%D1%80%...%201_%20_1_.pdf

 

 

 

IV NATIONAL CONFERENCE ON PREVENTION AND REHABILITATION

DISEASES OF DIGESTIVE "

X CONFERENCE OF GASTROENTEROLOGY OF SOUTHERN RUSSIA

 

Dear Colleague

We are honored to invite you to participate in the IV All-Russia

conference with international participation "Prevention and Rehabilitation

digestive diseases ÃÆâ€â„¢ÃƒÆ’ƒÂ¢Ãƒ¢Ã¢Ã¢â€š¬Ã…¡Ãƒâ€šÃ‚¬ÃƒÆ’…¡ÃƒÆ’â€Å¡Ãƒƒâہ¡ÃƒÆ’‚», X Conference of the South Gastroenterology

Russia, which will be held in Kislovodsk on 28-29 April 2011

 

And the part that has the Ropren presentation:

 

Lessons Hepatology II: Do hepatoprotectors in the treatment of chronic

nonviral diffuse liver diseases?

Chairs: A. Berry, Shatihin AI Golofeevsky VY

14:00 Some aspects of hepatoprotective therapy for alcohol

liver disease

Cortex, PV (Stavropol)

14:20 Beer alcoholism and liver damage

Shatihin AI (Moscow)

14:50 Medicinal liver disease: difficulties in diagnosis, approaches

to prevention and treatment

Korochanskaya NV (Krasnodar)

15:20 The role of the new combined hepatoprotector chronic

liver disease

Lahin VV (Voronezh)

15:50 Experience of polyprenols: ropren in patients with alcoholic

cirrhosis

Minushkin ON (Moscow)

16:10 Pathogenetic rationale and effectiveness suktsinatsoderzhaschih

drugs in the treatment of non-alcoholic fatty disease

Stelmach VV (St. Petersburg)

16:30 Closing

Link to comment
Share on other sites

Livas1 you really are the man :king:

I agree with you the Ropren trial looks to have been positive.

Professor Oleg wouldn't bother with Ropren unless it was the real deal why would he.

Interesting week coming up I'm sure those more informed investors will be onto this (might explain Fridays volume) and making their own assumptions on what it means. :)

Link to comment
Share on other sites

Hello forum. I've quickly noticed that once and for all, the large seller is exhausted. I suggest that Livas1 is spot on here and we'll be updated on this in April. I hope for 25c or more. I have had not much time of late to post but I thank all contributors. :blush:
Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now

×
×
  • Create New...